Literature DB >> 19022292

Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task.

Aurelio Campos-Romo1, Rafael Ojeda-Flores, Pablo Moreno-Briseño, Juan Fernandez-Ruiz.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder. An experimental model of this disease is produced in nonhuman primates by the administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this work, we put forward a new quantitative evaluation method that uses video recordings to measure the displacement, gate, gross and fine motor performance of freely moving subjects. Four Vervet monkeys (Cercopithecus aethiops) were trained in a behavioral observation hallway while being recorded with digital video cameras from four different angles. After MPTP intoxication the animals were tested without any drug and after 30 and 90 min of Levodopa/Carbidopa administration. Using a personal computer the following behaviors were measured and evaluated from the video recordings: displacement time across the hallway, reaching time towards rewards, ingestion time, number of attempts to obtain rewards, number of rewards obtained, and level of the highest shelf reached for rewards. Our results show that there was an overall behavioral deterioration after MPTP administration and an overall improvement after Levodopa/Carbidopa treatment. This demonstrates that the HALLWAY task is a sensitive and objective method that allows detailed behavioral evaluation of freely moving monkeys in the MPTP Parkinson's disease model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022292     DOI: 10.1016/j.jneumeth.2008.10.026

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  5 in total

1.  A web-based brain atlas of the vervet monkey, Chlorocebus aethiops.

Authors:  Roger P Woods; Scott C Fears; Matthew J Jorgensen; Lynn A Fairbanks; Arthur W Toga; Nelson B Freimer
Journal:  Neuroimage       Date:  2010-10-13       Impact factor: 6.556

2.  Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease.

Authors:  Maxwell B Santana; Pär Halje; Hougelle Simplício; Ulrike Richter; Marco Aurelio M Freire; Per Petersson; Romulo Fuentes; Miguel A L Nicolelis
Journal:  Neuron       Date:  2014-10-30       Impact factor: 17.173

Review 3.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

4.  Quantification of movement in normal and parkinsonian macaques using video analysis.

Authors:  Michael Caiola; Damien Pittard; Thomas Wichmann; Adriana Galvan
Journal:  J Neurosci Methods       Date:  2019-05-02       Impact factor: 2.390

Review 5.  Adenosine A(2A) Receptor Antagonists and Parkinson's Disease.

Authors:  Brian C Shook; Paul F Jackson
Journal:  ACS Chem Neurosci       Date:  2011-06-21       Impact factor: 4.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.